Inventor · disambiguated record
Weichun Chen
Also filed as: CHEN WEICHUN
10 granted patents·11 pending applications·12 citations·filing 2005–2025
80Inventor score
Files withHOFFMANN LA ROCHE7COLLETTI STEVEN L3NINGBO MOTOR IND CO LTD3CHEN WEICHUN2GLAXOSMITHKLINE IP DEV LTD2
Top patents by PatentIndex Score
21 records- 0181US8349852B2Quinazolinone derivatives useful as vanilloid antagonistsNOVARTIS AG·Filed 2010·Granted Jan 8, 2013·9 cites·5 claims
- 0262US2023242553A1Process for the preparation of 1-methyl-6-[6-r2-5-methyl-8-(methylamino)-4-[ (3as,6as)-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrol-1-yl]-9h-pyrido[2,3-b]indol-3-yl]-4-oxo-1,8-naphthyridine-3-carboxylic acid hydrochlorideHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0361US2024018143A1Process for the preparation of (9s)-n-[3-(6-methylpyrimidin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]-9-(2,3,4-trifluorophenyl)-6,7,8,9-tetrahydro-5h-[1,2,4]triazolo[1,5-a]azepin-2-amine and its solid formHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0460USD1061169SCup holderNINGBO MOTOR IND CO LTD·Filed 2023·Granted Feb 11, 2025·2 cites·1 claims
- 0554US2024025911A1Process for the preparation of 4-(3,5-difluorophenyl)-N-[3-(6-methylpyrimidin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]-6,7-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrimidin-2-amineHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0650US12319686B2Process for the preparation of tetrahydropyridopyrimidinesHOFFMANN LA ROCHE·Filed 2020·Granted Jun 3, 2025·0 cites·28 claims
- 0749USD1025457SAshtrayNINGBO MOTOR IND CO LTD·Filed 2022·Granted Apr 30, 2024·1 cites·1 claims
- 0849US2023048657A1Process for the preparation of (9s)-2-bromo-9-(2,3,4-trifluorophenyl)-6,7,8,9-tetrahydro-5h-[1,2,4]triazolo[1,5-a]azepineHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0948US8168649B2Niacin receptor agonists, compositions containing such compounds and methods of treatmentRAGHAVAN SUBHAREKHA·Filed 2006·Granted May 1, 2012·0 cites·20 claims
- 1045US12275709B2Process for the preparation of exo-tert-butyl N-(3-azabicyclo[3.2.1]octan-8-yl)carbamateHOFFMANN LA ROCHE·Filed 2019·Granted Apr 15, 2025·0 cites·14 claims
- 1145US10336719B21-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Jul 2, 2019·0 cites·15 claims
- 1245US2009170891A1Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of TreatmentCOLLETTI STEVEN L·Filed 2007·Application pending·0 cites
- 1344USD1096167SStorage box setCHEN WEICHUN·Filed 2025·Granted Oct 7, 2025·0 cites·1 claims
- 1443US2022162212A1Process for the preparation of (6s)-3-[(4s)-4-cyano-2-oxo-pyrrolidin-1-yl]-6-methyl-n-(3,4,5-trifluorophenyl)-6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine-5-carboxamideHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1542US2012178750A1Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of TreatmentRAGHAVAN SUBHAREKHA·Filed 2012·Application pending·0 cites
- 1641US2009042926A1Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of TreatmentIMBRIGLIO JASON·Filed 2006·Application pending·0 cites
- 1741US2007299101A1Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of TreatmentCOLLETTI STEVEN L·Filed 2005·Application pending·0 cites
- 1841US2007281969A1Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of TreatmentCOLLETTI STEVEN L·Filed 2005·Application pending·0 cites
- 1936USD1052965SDipping rackNINGBO MOTOR IND CO LTD·Filed 2023·Granted Dec 3, 2024·0 cites·1 claims
- 2036US10106515B21-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Oct 23, 2018·0 cites·12 claims
- 2136US2013060029A1Quinazolinone derivatives useful as vanilloid antagonistsCHEN WEICHUN·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Weichun Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →